Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Antiangiogenic therapy for glioma.

Cea V, Sala C, Verpelli C.

J Signal Transduct. 2012;2012:483040. doi: 10.1155/2012/483040. Epub 2012 Jul 8.

PMID:
22830012
[PubMed]
Free PMC Article
2.

Angiogenesis and invasion in glioma.

Onishi M, Ichikawa T, Kurozumi K, Date I.

Brain Tumor Pathol. 2011 Feb;28(1):13-24. doi: 10.1007/s10014-010-0007-z. Epub 2011 Jan 8. Review.

PMID:
21221826
[PubMed - indexed for MEDLINE]
3.

Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.

Onishi M, Kurozumi K, Ichikawa T, Date I.

Neurol Med Chir (Tokyo). 2013;53(11):755-63. Epub 2013 Oct 25.

PMID:
24162241
[PubMed - in process]
Free Article
4.

Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Rahman R, Smith S, Rahman C, Grundy R.

J Oncol. 2010;2010:251231. doi: 10.1155/2010/251231. Epub 2010 Apr 11.

PMID:
20414333
[PubMed]
Free PMC Article
5.

Biology of angiogenesis and invasion in glioma.

Tate MC, Aghi MK.

Neurotherapeutics. 2009 Jul;6(3):447-57. doi: 10.1016/j.nurt.2009.04.001. Review.

PMID:
19560735
[PubMed - indexed for MEDLINE]
6.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
[PubMed - indexed for MEDLINE]
7.

Progress on antiangiogenic therapy for patients with malignant glioma.

Ahluwalia MS, Gladson CL.

J Oncol. 2010;2010:689018. doi: 10.1155/2010/689018. Epub 2010 Apr 6.

PMID:
20379377
[PubMed]
Free PMC Article
8.

Inhibition of angiogenesis and invasion in malignant gliomas.

Chi A, Norden AD, Wen PY.

Expert Rev Anticancer Ther. 2007 Nov;7(11):1537-60. Review.

PMID:
18020923
[PubMed - indexed for MEDLINE]
9.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
[PubMed - indexed for MEDLINE]
10.

Primetime for antiangiogenic therapy.

Tabatabai G, Stupp R.

Curr Opin Neurol. 2009 Dec;22(6):639-44. doi: 10.1097/WCO.0b013e328332ba28. Review.

PMID:
19786873
[PubMed - indexed for MEDLINE]
11.

Antiangiogenic strategies for treatment of malignant gliomas.

Chi AS, Norden AD, Wen PY.

Neurotherapeutics. 2009 Jul;6(3):513-26. doi: 10.1016/j.nurt.2009.04.010. Review.

PMID:
19560741
[PubMed - indexed for MEDLINE]
12.

Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.

Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ.

Brain Res Brain Res Rev. 2004 Jul;45(3):143-63. Review.

PMID:
15210301
[PubMed - indexed for MEDLINE]
13.

Angiogenesis and antiangiogenic therapy for malignant gliomas.

Takano S, Kamiyama H, Tsuboi K, Matsumura A.

Brain Tumor Pathol. 2004;21(2):69-73.

PMID:
15700836
[PubMed - indexed for MEDLINE]
14.

Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.

Jeffes EW, Zhang JG, Hoa N, Petkar A, Delgado C, Chong S, Obenaus A, Sanchez R, Khalaghizadeh S, Khomenko T, Knight BA, Alipanah R, Nguyen TV, Shah C, Vohra S, Zhuang JL, Liu J, Wepsic HT, Jadus MR.

J Immunol. 2005 Mar 1;174(5):2533-43.

PMID:
15728459
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition of angiogenesis as a therapeutic strategy against brain tumors.

Puduvalli VK.

Cancer Treat Res. 2004;117:307-36. Review.

PMID:
15015567
[PubMed - indexed for MEDLINE]
16.

Angiogenesis in cancer: molecular mechanisms, clinical impact.

Eichhorn ME, Kleespies A, Angele MK, Jauch KW, Bruns CJ.

Langenbecks Arch Surg. 2007 May;392(3):371-9. Epub 2007 Feb 16. Review.

PMID:
17458577
[PubMed - indexed for MEDLINE]
17.

Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor.

Cuevas P, Carceller F, Angulo J, González-Corrochano R, Cuevas-Bourdier A, Giménez-Gallego G.

Neurosci Lett. 2011 Mar 10;491(1):1-7. doi: 10.1016/j.neulet.2010.12.047. Epub 2010 Dec 28.

PMID:
21193016
[PubMed - indexed for MEDLINE]
18.

Antiangiogenic therapy in brain tumor models.

Bernsen HJ, van der Kogel AJ.

J Neurooncol. 1999;45(3):247-55. Review.

PMID:
10845396
[PubMed - indexed for MEDLINE]
19.

Molecular therapeutic targets for glioma angiogenesis.

Takano S, Yamashita T, Ohneda O.

J Oncol. 2010;2010:351908. doi: 10.1155/2010/351908. Epub 2010 Apr 18.

PMID:
20414463
[PubMed]
Free PMC Article
20.

Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Vajkoczy P, Knyazev P, Kunkel A, Capelle HH, Behrndt S, von Tengg-Kobligk H, Kiessling F, Eichelsbacher U, Essig M, Read TA, Erber R, Ullrich A.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5799-804. Epub 2006 Apr 3.

PMID:
16585512
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk